🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/09/2010 | 56,44 | 57,16 | 55,91 | 56,01 | -0,11% | 2,21% | 1.292.300 |
| 29/09/2010 | 55,83 | 56,65 | 55,73 | 56,07 | +0,04% | 1,65% | 1.121.100 |
| 28/09/2010 | 55,70 | 56,35 | 55,63 | 56,05 | +0,72% | 1,29% | 1.175.800 |
| 27/09/2010 | 55,44 | 55,96 | 54,86 | 55,65 | +0,29% | 1,98% | 811.900 |
| 24/09/2010 | 54,93 | 55,55 | 54,37 | 55,49 | +2,15% | 2,15% | 569.200 |
| 23/09/2010 | 54,01 | 54,62 | 53,80 | 54,32 | -0,04% | 1,52% | 593.200 |
| 22/09/2010 | 53,88 | 55,00 | 53,88 | 54,34 | +0,31% | 2,08% | 500.100 |
| 21/09/2010 | 54,15 | 54,63 | 53,91 | 54,17 | -0,44% | 1,33% | 478.400 |
| 20/09/2010 | 55,00 | 55,00 | 53,97 | 54,41 | -0,27% | 1,87% | 541.800 |
| 17/09/2010 | 53,19 | 54,92 | 53,02 | 54,56 | +5,43% | 3,57% | 3.717.900 |
| 16/09/2010 | 51,42 | 51,90 | 51,05 | 51,75 | +0,74% | 1,65% | 460.000 |
| 15/09/2010 | 50,48 | 51,70 | 50,48 | 51,37 | +1,34% | 2,42% | 772.000 |
| 14/09/2010 | 50,41 | 50,99 | 50,21 | 50,69 | +0,78% | 1,55% | 356.000 |
| 13/09/2010 | 51,28 | 51,38 | 49,84 | 50,30 | -1,30% | 3,00% | 598.800 |
| 10/09/2010 | 49,79 | 51,50 | 49,68 | 50,96 | +2,54% | 3,66% | 854.600 |
| 09/09/2010 | 49,12 | 49,81 | 48,98 | 49,70 | +2,39% | 1,69% | 1.127.900 |
| 08/09/2010 | 48,78 | 49,00 | 48,38 | 48,54 | -0,49% | 1,27% | 383.100 |
| 07/09/2010 | 49,74 | 49,94 | 48,40 | 48,78 | -2,24% | 3,10% | 404.500 |
| 03/09/2010 | 49,12 | 50,00 | 48,91 | 49,90 | +2,78% | 2,22% | 823.800 |
| 02/09/2010 | 47,19 | 48,82 | 46,76 | 48,55 | +2,95% | 4,37% | 751.700 |
| 01/09/2010 | 46,82 | 47,30 | 46,55 | 47,16 | +2,03% | 1,60% | 319.800 |
| 31/08/2010 | 46,47 | 47,10 | 46,16 | 46,22 | -0,94% | 2,02% | 562.200 |
| 30/08/2010 | 47,16 | 47,18 | 46,64 | 46,66 | -1,69% | 1,15% | 548.700 |
| 27/08/2010 | 47,17 | 47,82 | 46,37 | 47,46 | +1,17% | 3,07% | 277.000 |
| 26/08/2010 | 47,45 | 47,50 | 46,37 | 46,91 | -0,91% | 2,38% | 773.800 |
| 25/08/2010 | 46,61 | 47,41 | 46,14 | 47,34 | +1,09% | 2,72% | 695.100 |
| 24/08/2010 | 47,06 | 47,25 | 46,75 | 46,83 | -1,45% | 1,06% | 339.900 |
| 23/08/2010 | 48,02 | 48,02 | 47,35 | 47,52 | -0,40% | 1,40% | 535.200 |
| 20/08/2010 | 48,00 | 48,11 | 47,60 | 47,71 | -0,98% | 1,06% | 565.700 |
| 19/08/2010 | 49,33 | 49,57 | 47,87 | 48,18 | -2,96% | 3,45% | 494.500 |